The Claim
Patients with lung squamous cell carcinoma classified as high-risk by a copper-induced cell death-related lncRNA risk score have higher TIDE scores than low-risk patients, indicating a greater degree of immune evasion and reduced benefit from immunotherapy.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In patients with lung squamous cell carcinoma, those identified as high-risk by a specific genetic risk score show stronger signs of immune system suppression and respond less effectively to immunotherapy compared to those classified as low-risk.
See the scientific wording
Patients with lung squamous cell carcinoma classified as high-risk by a copper-induced cell death-related lncRNA risk score exhibit higher TIDE scores, indicating greater likelihood of immune evasion and reduced benefit from immunotherapy, compared to low-risk patients.
Specific long RNA molecules triggered by copper buildup in tumor cells block signals that would normally alert immune cells, making the cancer invisible to immune attack and reducing the effectiveness of treatments designed to activate the immune system.
What the research says
1 studyScientists found that lung cancer patients with a specific genetic signature are more likely to have tumors that hide from the immune system, making immunotherapy less effective for them.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.